Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. buy Xetrakarl

Start price
€32.30
17.07.23 / 50%
Target price
€45.00
17.07.24
Performance (%)
-13.54%
Price
€26.01
19:01
Summary
This prediction is currently active. The prediction for Pfizer Inc. disappoints with a performance of -13.54%. A total of €1.92 was paid as dividends for this prediction. This prediction currently runs until 17.07.24. The prediction end date can be changed by Xetrakarl at any time. Xetrakarl has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Pfizer Inc. 0.929% 0.929%
iShares Core DAX® 4.015% 2.971%
iShares Nasdaq 100 2.755% 0.503%
iShares Nikkei 225® -0.826% -5.057%
iShares S&P 500 2.330% 0.720%

Comments by Xetrakarl for this prediction

In the thread Pfizer Inc. diskutieren
Prediction Buy
Perf. (%) -13.54%
Target price 45.000
Change
Ends at 17.07.24

Die diese Pharmaktie ist sehr günstig bewertet-. Langfristig dürfte sie nur zu wesentlich höheren Kursen handelbar sein. Interessant ist auch die regelmäßige Dividendenzahlung und das relativ niedrige KGV. Die derzeit niedrige Bewertung bietet Langfristanlegern eine günstige Einstiegsmöglichkeit